Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125693092 | 12569309 | 2 | F | 20160712 | 20160719 | 20160720 | EXP | PHHY2016ES096069 | SANDOZ | PASCUAL O, URIARTE M, AGUSTIN MJ, GIMENO V, LARRODE I, ABAD MR. TWO CASES OF BREAST CARCINOMA DURING PREGNANCY AND REVIEW OF THE LITERATURE. JOURNAL OF ONCOLOGY PHARMACY PRACTICE. 2016;22(4):652-6 | 33.00 | YR | F | Y | 0.00000 | 20160720 | OT | ES | ES |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125693092 | 12569309 | 1 | SS | ONDANSETRON | ONDANSETRON | 1 | Intravenous (not otherwise specified) | U | 0 | ||||||||||
125693092 | 12569309 | 2 | PS | DOXORUBICIN | DOXORUBICIN | 1 | Intravenous (not otherwise specified) | 25 MG/M2, -3 EVERY THREE WEEKS | U | 200146 | 25 | MG/M**2 | |||||||
125693092 | 12569309 | 3 | SS | PACLITAXEL. | PACLITAXEL | 1 | Intravenous (not otherwise specified) | 80 MG/M2, QW | U | 0 | 80 | MG/M**2 | /wk |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125693092 | 12569309 | 1 | Vomiting |
125693092 | 12569309 | 2 | Invasive ductal breast carcinoma |
125693092 | 12569309 | 3 | Invasive ductal breast carcinoma |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125693092 | 12569309 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125693092 | 12569309 | Anaemia | |
125693092 | 12569309 | Fatigue | |
125693092 | 12569309 | Maternal exposure during pregnancy | |
125693092 | 12569309 | Neutropenia | |
125693092 | 12569309 | Premature delivery | |
125693092 | 12569309 | Pyrexia | |
125693092 | 12569309 | Respiratory tract infection | |
125693092 | 12569309 | Therapy non-responder |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |